Wenbin Li, Zhuang Kang, Shenglan Li, Manxi Zhao, Yan Li, Wenguo Yin, Xiao Ke. "A phase I study to assess the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of KH617 for patients with advanced solid tumors (including diffuse gliomas of adulthood).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.2046